FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386591374> ?p ?o ?g. }

• W4386591374 endingPage "101602" @default.
• W4386591374 startingPage "101602" @default.
• W4386591374 abstract "While prognosis for patients with chronic lymphocytic leukemia (CLL) has improved over time in younger adults, only modest improvements have occurred in older adults. We conducted a descriptive study of prognosis in older adults with CLL.We used data from the Surveillance, Epidemiology, and End Results (SEER)-Medicare database from 2003 to 2016. We identified older adults (≥66 years) diagnosed with primary CLL between 2004 and 2015 (Overall Cohort). A subset who initiated CLL-directed therapy during the year following diagnosis was also identified (Treated Cohort). Both cohorts were matched to Medicare beneficiaries without cancer based on age, sex, and region. For each year from 2004 to 2013, three-year survival for patients with CLL and non-cancer comparators was described using Kaplan-Meier analysis. Inverse probability weighted Cox regression models were used to compare survival in the CLL and non-cancer comparator cohorts, accounting for demographic information and comorbidity and frailty indices. Among older adults with CLL, ten-year cause-specific cumulative mortality was estimated using Aalen-Johansen estimators that accounted for competing risks. Predictors of cause-specific mortality, including comorbidity and frailty burden, were assessed using sub-distribution hazards models.In the Overall Cohort, three-year survival increased non-monotonically from 71.4% in 2004 to 73.4% in 2013, with a peak of 74.4% in 2011, and was lower than survival in non-cancer comparators (78.3% in 2004 to 83.2% in 2013). In the Treated Cohort, three-year survival was 56.3% in 2004 and 56.5% in 2013, with a peak of 64.2% in 2011. Cox models suggested that survival in the Treated Cohort was approaching survival in non-cancer comparators after 2011 (hazard ratio = 1.04, 95% confidence interval, 0.93-1.17). Ten-year cumulative mortality was 68.6% in the Overall Cohort and 81.7% in the Treated Cohort, with most deaths attributed to non-CLL causes. In the sub-distribution hazards models, age, year of diagnosis, frailty, and comorbidities were all associated with prognosis.Prognosis in older adults has been stable over time and most patients with CLL die from non-CLL causes. CLL-directed treatment decision-making in older adults should consider age-related factors, such as comorbidity and frailty." @default.
• W4386591374 created "2023-09-12" @default.
• W4386591374 creator A5015991104 @default.
• W4386591374 creator A5025285495 @default.
• W4386591374 creator A5030530617 @default.
• W4386591374 creator A5036291591 @default.
• W4386591374 creator A5081197909 @default.
• W4386591374 date "2023-11-01" @default.
• W4386591374 modified "2023-09-29" @default.
• W4386591374 title "Prognosis of older adults with chronic lymphocytic leukemia: A Surveillance, Epidemiology, and End Results-Medicare cohort study" @default.
• W4386591374 cites W1747288778 @default.
• W4386591374 cites W1783351295 @default.
• W4386591374 cites W1974855794 @default.
• W4386591374 cites W1975590576 @default.
• W4386591374 cites W1988682601 @default.
• W4386591374 cites W1993678255 @default.
• W4386591374 cites W2000445173 @default.
• W4386591374 cites W2062946371 @default.
• W4386591374 cites W2066564017 @default.
• W4386591374 cites W2076804009 @default.
• W4386591374 cites W2078045353 @default.
• W4386591374 cites W2098223916 @default.
• W4386591374 cites W2108326787 @default.
• W4386591374 cites W2120319857 @default.
• W4386591374 cites W2129168200 @default.
• W4386591374 cites W2129380253 @default.
• W4386591374 cites W2131078883 @default.
• W4386591374 cites W2136975742 @default.
• W4386591374 cites W2138740885 @default.
• W4386591374 cites W2140606816 @default.
• W4386591374 cites W2186729366 @default.
• W4386591374 cites W2304987096 @default.
• W4386591374 cites W2396328865 @default.
• W4386591374 cites W2419545438 @default.
• W4386591374 cites W2548089616 @default.
• W4386591374 cites W2606119962 @default.
• W4386591374 cites W2622422839 @default.
• W4386591374 cites W2697497789 @default.
• W4386591374 cites W2765198264 @default.
• W4386591374 cites W2771285175 @default.
• W4386591374 cites W2788803761 @default.
• W4386591374 cites W2795614055 @default.
• W4386591374 cites W2802007547 @default.
• W4386591374 cites W2804780558 @default.
• W4386591374 cites W2889484102 @default.
• W4386591374 cites W2902706178 @default.
• W4386591374 cites W2915807841 @default.
• W4386591374 cites W2921045850 @default.
• W4386591374 cites W2946882253 @default.
• W4386591374 cites W2948436219 @default.
• W4386591374 cites W2980937306 @default.
• W4386591374 cites W3007437815 @default.
• W4386591374 cites W3014623058 @default.
• W4386591374 cites W3016538158 @default.
• W4386591374 cites W3091199432 @default.
• W4386591374 cites W4206841660 @default.
• W4386591374 cites W4235474157 @default.
• W4386591374 cites W4328135909 @default.
• W4386591374 doi "https://doi.org/10.1016/j.jgo.2023.101602" @default.
• W4386591374 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37696241" @default.
• W4386591374 hasPublicationYear "2023" @default.
• W4386591374 type Work @default.
• W4386591374 citedByCount "0" @default.
• W4386591374 crossrefType "journal-article" @default.
• W4386591374 hasAuthorship W4386591374A5015991104 @default.
• W4386591374 hasAuthorship W4386591374A5025285495 @default.
• W4386591374 hasAuthorship W4386591374A5030530617 @default.
• W4386591374 hasAuthorship W4386591374A5036291591 @default.
• W4386591374 hasAuthorship W4386591374A5081197909 @default.
• W4386591374 hasConcept C10515644 @default.
• W4386591374 hasConcept C107130276 @default.
• W4386591374 hasConcept C121608353 @default.
• W4386591374 hasConcept C126322002 @default.
• W4386591374 hasConcept C144024400 @default.
• W4386591374 hasConcept C149923435 @default.
• W4386591374 hasConcept C201903717 @default.
• W4386591374 hasConcept C2777938653 @default.
• W4386591374 hasConcept C2778461978 @default.
• W4386591374 hasConcept C2778527826 @default.
• W4386591374 hasConcept C2779159551 @default.
• W4386591374 hasConcept C2779391198 @default.
• W4386591374 hasConcept C50382708 @default.
• W4386591374 hasConcept C71924100 @default.
• W4386591374 hasConcept C72563966 @default.
• W4386591374 hasConcept C74909509 @default.
• W4386591374 hasConceptScore W4386591374C10515644 @default.
• W4386591374 hasConceptScore W4386591374C107130276 @default.
• W4386591374 hasConceptScore W4386591374C121608353 @default.
• W4386591374 hasConceptScore W4386591374C126322002 @default.
• W4386591374 hasConceptScore W4386591374C144024400 @default.
• W4386591374 hasConceptScore W4386591374C149923435 @default.
• W4386591374 hasConceptScore W4386591374C201903717 @default.
• W4386591374 hasConceptScore W4386591374C2777938653 @default.
• W4386591374 hasConceptScore W4386591374C2778461978 @default.
• W4386591374 hasConceptScore W4386591374C2778527826 @default.
• W4386591374 hasConceptScore W4386591374C2779159551 @default.
• W4386591374 hasConceptScore W4386591374C2779391198 @default.
• W4386591374 hasConceptScore W4386591374C50382708 @default.

• next